Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress

The most common primary intracranial tumor is glioma, among which glioblastoma (GBM) has the worst prognosis. Because of the high degree of malignancy of GBM and frequent recurrence after surgery, postoperative therapy, including chemotherapy, radiotherapy, targeted therapy, and immunotherapy, is pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yaning, Chen, Wanqi, Shi, Yixin, Yan, Chengrui, Kong, Ziren, Wang, Yuekun, Wang, Yu, Ma, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458950/
https://www.ncbi.nlm.nih.gov/pubmed/34568049
http://dx.doi.org/10.3389/fonc.2021.719623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458950/
https://www.ncbi.nlm.nih.gov/pubmed/34568049
http://dx.doi.org/10.3389/fonc.2021.719623

Ejemplares similares